(4R)-limonene
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- (4R)-limonene
- DrugBank Accession Number
- DB08921
- Background
Limonene is common in cosmetic products. As the main odor constituent of citrus (plant family Rutaceae), D-limonene is used in food manufacturing and some medicines, e.g. as a flavoring to mask the bitter taste of alkaloids, and as a fragrant in perfumery.
- Type
- Small Molecule
- Groups
- Investigational
- Structure
- Weight
- Average: 136.234
Monoisotopic: 136.125200512 - Chemical Formula
- C10H16
- Synonyms
- (+)-(4R)-Limonene
- (+)-(R)-Limonene
- (+)-4-isopropenyl-1-methylcyclohexene
- (+)-Limonene
- (4R)-1-methyl-4-isopropenylcyclohex-1-ene
- (4R)-4-isopropenyl-1-methylcyclohexene
- (R)-(+)-limonene
- (R)-(+)-p-mentha-1,8-diene
- (R)-1-methyl-4-(1-methylethenyl)cyclohexene
- (R)-4-isopropenyl-1-methyl-1-cyclohexene
- (R)-p-mentha-1,8-diene
- 4βH-p-mentha-1,8-diene
- D-(+)-limonene
- D-Limonen
- D-limonene
- External IDs
- FEMA NO. 2633
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
Hover over products below to view reaction partners
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Purifying Balance Soothing Peeling Pad Liquid 0.00185573 g/100mL Topical inthismorning co ltd 2023-01-15 Not applicable US Purifying Balance Soothing Peeling Pad Liquid 0.005016382 g/100mL Topical inthismorning co ltd 2023-01-15 Not applicable US Purifying S.O.S spotgel Gel 0.005016382 g/100mL Topical inthismorning co ltd 2023-01-15 Not applicable US - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Purifying Balance Soothing Peeling Pad (4R)-limonene (0.00185573 g/100mL) Liquid Topical inthismorning co ltd 2023-01-15 Not applicable US Purifying Balance Soothing Peeling Pad (4R)-limonene (0.005016382 g/100mL) Liquid Topical inthismorning co ltd 2023-01-15 Not applicable US Purifying S.O.S spotgel (4R)-limonene (0.005016382 g/100mL) Gel Topical inthismorning co ltd 2023-01-15 Not applicable US
Categories
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as menthane monoterpenoids. These are monoterpenoids with a structure based on the o-, m-, or p-menthane backbone. P-menthane consists of the cyclohexane ring with a methyl group and a (2-methyl)-propyl group at the 1 and 4 ring position, respectively. The o- and m- menthanes are much rarer, and presumably arise by alkyl migration of p-menthanes.
- Kingdom
- Organic compounds
- Super Class
- Lipids and lipid-like molecules
- Class
- Prenol lipids
- Sub Class
- Monoterpenoids
- Direct Parent
- Menthane monoterpenoids
- Alternative Parents
- Monocyclic monoterpenoids / Branched unsaturated hydrocarbons / Cycloalkenes / Unsaturated aliphatic hydrocarbons
- Substituents
- Aliphatic homomonocyclic compound / Branched unsaturated hydrocarbon / Cyclic olefin / Cycloalkene / Hydrocarbon / Monocyclic monoterpenoid / Olefin / P-menthane monoterpenoid / Unsaturated aliphatic hydrocarbon / Unsaturated hydrocarbon
- Molecular Framework
- Aliphatic homomonocyclic compounds
- External Descriptors
- limonene (CHEBI:15382) / Menthane monoterpenoids, Cyclic monoterpenes (C06099) / Menthane monoterpenoids (LMPR0102090013)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- GFD7C86Q1W
- CAS number
- 5989-27-5
- InChI Key
- XMGQYMWWDOXHJM-JTQLQIEISA-N
- InChI
- InChI=1S/C10H16/c1-8(2)10-6-4-9(3)5-7-10/h4,10H,1,5-7H2,2-3H3/t10-/m0/s1
- IUPAC Name
- (4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-1-ene
- SMILES
- CC(=C)[C@@H]1CCC(C)=CC1
References
- General References
- Not Available
- External Links
- Human Metabolome Database
- HMDB0004321
- KEGG Drug
- D00194
- KEGG Compound
- C06099
- ChemSpider
- 389747
- 1426476
- ChEBI
- 15382
- ChEMBL
- CHEMBL449062
- ZINC
- ZINC000000967513
- PDBe Ligand
- 9IR
- Wikipedia
- Limonene
- PDB Entries
- 7sji
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 2 Unknown Status Treatment Genital Human Papilloma Virus Infection 1 1 Recruiting Supportive Care Dry Mouth 1 0 Completed Other Parotid Gland Tumor / Submandibular Gland Tumor 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Liquid Topical 0.00185573 g/100mL Liquid Topical 0.005016382 g/100mL Gel Topical 0.005016382 g/100mL - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.457 mg/mL ALOGPS logP 4.5 ALOGPS logP 3.22 Chemaxon logS -2.5 ALOGPS Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 0 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 0 Å2 Chemaxon Rotatable Bond Count 1 Chemaxon Refractivity 46.48 m3·mol-1 Chemaxon Polarizability 17.55 Å3 Chemaxon Number of Rings 1 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule Yes Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 132.6710023 predictedDarkChem Lite v0.1.0 [M-H]- 132.3857023 predictedDarkChem Lite v0.1.0 [M-H]- 132.1641023 predictedDarkChem Lite v0.1.0 [M-H]- 132.0589023 predictedDarkChem Lite v0.1.0 [M-H]- 131.82327 predictedDeepCCS 1.0 (2019) [M+H]+ 134.48186 predictedDeepCCS 1.0 (2019) [M+Na]+ 142.80159 predictedDeepCCS 1.0 (2019)
Drug created at September 03, 2013 20:56 / Updated at June 12, 2020 16:52